Prevention, Intervention, and Care of Neurodegerative Diseases
A special issue of Healthcare (ISSN 2227-9032). This special issue belongs to the section "Chronic Care".
Deadline for manuscript submissions: closed (31 October 2022) | Viewed by 22299
Special Issue Editors
Interests: neuroimaging; cognition disorders; multiple sclerosis; neuroimmunology
Special Issues, Collections and Topics in MDPI journals
Interests: neuroimmunology; neurodegenerative diseases; multiple sclerosis; neuroimaging; biomarkers; cognitive neuropsychology
Special Issues, Collections and Topics in MDPI journals
Interests: neuroimmunology; neurodegenerative diseases; multiple sclerosis; neuroimaging; biomarkers; cognitive neuropsychology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Our current ability to detect neurodegenerative diseases early and manage them is limited. The insidious processes underlying these conditions are only partly understood, while the treatments used have limited efficacies. Current research aims to understand the mechanisms underlying the progressive axonal loss in various neurologic conditions and seeks ways to properly monitor, quantify, and treat their relevant clinical implications.
This Special Issue of Healthcare seeks commentaries, original research, short reports, and reviews focussing on challenges in detecting, monitoring, and treating neurodegenerative diseases. This Special Issue aims to provide information about advances in the research of various primarily neurodegenerative conditions such as dementia, Parkinson’s Disease, motor neurone disease, and diseases with evident neurodegenerative components such as multiple sclerosis.
Dr. Christos Bakirtzis
Prof. Dr. Marina Kleopatra Boziki
Prof. Dr. Nikolaos Grigoriadis
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neurodegeneration
- axonal loss
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.